Catheter-Based Treatment for Patients With Acute Ischemic Stroke Ineligible for Intravenous Thrombolysis
Open Access
- 1 May 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 35 (5) , e109-e111
- https://doi.org/10.1161/01.str.0000125711.94465.78
Abstract
Background and Purpose— We present our single-center experience using catheter-based therapy for acute ischemic stroke patients who were not candidates for intravenous thrombolytic therapy. Methods— Neurologic outcomes were assessed in patients with acute ischemic stroke, ineligible for intravenous thrombolysis, treated with an emergent catheter-based therapy. Results— Nonparametric analysis of neurological outcomes demonstrated a benefit in National Institutes of Health Stroke Scale (NIHSS) at long-term follow-up ( P =0.036). Independence in daily activities and improvement in NIHSS of ≥4 points were achieved in 38% and 56% of patients, respectively. Four patients (25%) died, including 2 patients (12.5%) who died from intracranial hemorrhage. Conclusions— Catheter-based treatment offers a promising treatment strategy in patients with acute ischemic stroke ineligible for intravenous thrombolysis.Keywords
This publication has 4 references indexed in Scilit:
- Why are stroke patients excluded from TPA therapy?Neurology, 2001
- Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute StrokeJAMA, 2000
- Intra-arterial Prourokinase for Acute Ischemic StrokeJAMA, 1999
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995